GLOW (BBG70)
Peptide blend researched for skin health and collagen support.
GLOW (BBG70)
Background
GLOW (also designated BBG70) is a research blend that commonly combines BPC-157, TB-500, and the copper tripeptide GHK-Cu. The rationale studied in the literature is the convergence of complementary repair-associated pathways: angiogenesis and growth-factor signaling (BPC-157), actin regulation and cell migration (TB-500), and collagen/matrix remodeling (GHK-Cu).
No controlled studies characterize this specific combination; the supporting evidence consists of separate preclinical work on each component. See the individual component entries for primary references.
Selected literature
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide. International Journal of Molecular Sciences. 2018;19(7):1987.
- Sikiric P, et al. Brain-gut axis and pentadecapeptide BPC 157. Current Neuropharmacology. 2016;14(8):857-865.
- Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine. 2005;11(9):421-429.
References are provided for scientific context only. Citation does not imply endorsement of any use, nor a claim of safety or efficacy. Findings frequently derive from in-vitro or animal models.
Trademarks & attribution
GLOW (BBG70) is a research blend; its component compounds (BPC-157, TB-500, GHK-Cu) are investigational or non-trademark-restricted and carry the attributions noted on their individual entries. Catalyst Research Labs is not affiliated with any branded product. Supplied as reference material only.
